Omlan, Cherie .

HRN: 25-57-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
CEFTRIAXONE 1G (VIAL)
02/05/2026
02/11/2026
IV DRIP
790mg
Q24
Impetigo; Dermatitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: